Content about Ortho-McNeil-Janssen

July 29, 2011
Hi-Tech Pharmacal introduces generic Levaquin

A generic version of a popular pneumonia treatment has entered the market from Hi-Tech Pharmacal.

AMITYVILLE, N.Y. — A generic version of a popular pneumonia treatment has entered the market from Hi-Tech Pharmacal.

Hi-Tech Pharmacal has introduced levofloxacin oral solution in the 25-mg/mL strength. The drug will be available in 480-mL, 200-mL and 100-mL sizes in order to allow pharmacists to tailor inventory to store volume. As previously reported by Drug Store News, Hi-Tech Pharmacal was granted tentative approval for the drug in April.

May 2, 2011
Watson's generic Concerta enters market

Watson Pharmaceuticals has launched an authorized generic version of a Johnson & Johnson drug for treating attention deficit hyperactivity disorder through a subsidiary, Watson said Monday.

PARSIPPANY, N.J. — Watson Pharmaceuticals has launched an authorized generic version of a Johnson & Johnson drug for treating attention deficit hyperactivity disorder through a subsidiary, Watson said Monday.

Watson announced the launch by Watson Labs of methylphenidate hydrochloride extended-release tablets under an agreement with J&J subsidiary Ortho-McNeil-Janssen.

April 11, 2011
Invega approved as schizophrenia treatment for adolescents

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating schizophrenia in adolescents.

TITUSVILLE, N.J. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating schizophrenia in adolescents.

J&J said Monday that the FDA had approved Invega (paliperidone) extended-release tablets for patients ages 12 to 17 years. The drug is marketed by J&J subsidiary Ortho-McNeil-Janssen Pharmaceuticals. The drug originally was approved in 2006 for treating schizophrenia in adults.

November 1, 2010
Watson to market, distribute authorized generic ADHD drug

Generic drug maker Watson Pharmaceuticals will distribute an authorized generic version of a drug used...

MORRISTOWN, N.J. Generic drug maker Watson Pharmaceuticals will distribute an authorized generic version of a drug used to treat attention deficit hyperactivity disorder, Watson said Tuesday.

Watson entered an agreement with Johnson & Johnson subsidiary Ortho-McNeil-Janssen Pharmaceuticals to distribute an authorized generic of Concerta (methylphenidate hydrochloride) extended-release tablets. An authorized generic is a branded drug sold under its generic name, usually by a third-party company.

June 21, 2010
Metabolex inks deal with J&J for diabetes treatment

Metabolex has entered an agreement to discover and develop Type 2 diabetes drugs with a...

May 23, 2010
J&J subsidiaries to pay government for alleged Topamax promotion

Two subsidiaries of Johnson & Johnson will pay more than $81 million to the federal...